Safety of anticoagulation in patients with atrial fibrillation and MDS/AML complicated by thrombocytopenia: An unresolved challenge: Can they be managed? A report of three cases and literature review

Am J Hematol. 2018 May;93(5):E112-E114. doi: 10.1002/ajh.25045. Epub 2018 Feb 14.

Authors

Jessica Caro¹, Shyamala Navada²

Affiliations

¹ Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
² Division of Hematology/Oncology, Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.

PMID: 29352736
DOI: 10.1002/ajh.25045

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Aged, 80 and over
Anticoagulants / therapeutic use*
Atrial Fibrillation / complications*
Atrial Fibrillation / drug therapy
Disease Management
Female
Hemorrhage / etiology
Humans
Leukemia, Myeloid, Acute / complications*
Leukemia, Myeloid, Acute / drug therapy
Male
Myelodysplastic Syndromes / complications*
Myelodysplastic Syndromes / drug therapy
Thrombocytopenia / etiology*

Substances

Anticoagulants